UBS’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$388K Buy
19,700
+2,477
+14% +$51K ﹤0.01% 4521
2014
Q2
$412K Sell
17,223
-2,258
-12% -$54.5K ﹤0.01% 4411
2014
Q1
$518K Sell
19,481
-2,721
-12% -$64.7K ﹤0.01% 4190
2013
Q4
$448K Buy
22,202
+10,902
+96% +$202K ﹤0.01% 4461
2013
Q3
$197K Sell
11,300
-28,924
-72% -$501K ﹤0.01% 5202
2013
Q2
$678K Buy
+40,224
New +$621K ﹤0.01% 3756

Other funds holding GMED

UBS's GMED Position: Q3 2014 in Review

UBS increased its Globus Medical (GMED) stake by 14% in Q3 2014, buying an estimated $51K and bringing the position to 19,700 shares worth $388K. The position accounts for ﹤0.01% of the portfolio, ranked #4521.

UBS first reported a position in GMED in Q2 2013 and has held it in 6 quarters since. The position peaked at $678K in Q2 2013. 166 funds tracked by Wall St. Rank hold GMED as of Q3 2014.

  • UBS held 19,700 shares of Globus Medical worth $388K as of Q3 2014.
  • UBS bought 2,477 Globus Medical shares in Q3 2014, an estimated $51K.
  • Globus Medical made up ﹤0.01% of UBS's portfolio in Q3 2014, its #4521 holding.
  • UBS first reported a position in Globus Medical in Q2 2013 and has held it in 6 quarters since.
  • UBS's Globus Medical position peaked at $678K in Q2 2013.
  • 166 funds tracked by Wall St. Rank held Globus Medical as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.